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The purpose of this article is to present lessons
learned in neurodevelopmental assessment
of children from the Centers for Children’s
Environmental Health and Disease Prevention
Research (Children’s Centers) and from previ-
ous research. These comments and recommen-
dations are products of the authors’ experiences
within their centers and their past works in the
area of environmental neurotoxicology and ter-
atology. We present both missteps and achieve-
ments in the hope that our collective experience
can help guide in the planning and implemen-
tation of the National Children’s Study.
The Central Nervous System
as a Critical Organ
A fundamental lesson learned from studies of
the effects of environmental exposures to the
fetus and child is that the developing brain is
one of the organs in the human body most
sensitive to damage. Functional manifesta-
tions ranging from frank mental retardation
to milder learning disabilities are the most
common class of birth defects (Lipkin 1991),
although in most cases the speciﬁc etiology is
unknown (Kallen 1988). Researchers have
speculated that some cases of uncertain etiol-
ogy may be due to environmental chemical
exposures (Rees et al. 1990). The maturation
of the central nervous system requires a more
complex sequence of processes than any other
structure, making this organ uniquely vul-
nerable to environmental influences (Rodier
1994, 2004).
National and international agencies have
focused on the risks of early exposure to sev-
eral major environmental contaminants such
as lead, methylmercury, and polychlorinated
biphenyls (PCBs) on neurodevelopment
[Agency for Toxic Substances and Disease
Registry (ATSDR) 2000; International
Programme on Chemical Safety (IPCS) 1995;
National Research Council 2000]. Although
there is a paucity of data on the risks of lower-
level pesticide exposures on human neuro-
development, there are substantial animal
model data and limited human developmental
data that these poisons may affect intrauterine
growth and have functional teratogenic prop-
erties as well (Guillette et al. 1998; Weiss
1997; Weiss et al. 2004).
Initial Considerations
Timing of neurodevelopmental assessment.
The vast and rapid growth of the child’s neuro-
behavioral repertoire from birth through ado-
lescence means that functional expressions
of earlier-damaged systems may not be pre-
sent or accessible at any given moment in
time. For example, finding no effects on
infant behavior cannot be regarded as conclu-
sive evidence that the toxic agent has had no
impact. Negative findings in the preschool
period are also inconclusive. A toxicant may
damage higher cortical centers that are associ-
ated with neurocognitive processes that are
not yet functional or only marginally func-
tional in a preschooler. In older children, a
wider and more differentiated range of abili-
ties can be examined, scores on psychometric
measures are more precise and reliable, and
early academic performance and social func-
tioning outside of the home environment can
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Principles and practices of pediatric neurotoxicology are reviewed here with the purpose of
guiding the design and execution of the planned National Children’s Study. The developing
human central nervous system is the target organ most vulnerable to environmental chemicals. An
investigation of the effects of environmental exposures on child development is a complex
endeavor that requires consideration of numerous critical factors pertinent to a study’s concept,
design, and execution. These include the timing of neurodevelopmental assessment, matters of bio-
logic plausibility, site, child and population factors, data quality assurance and control, the selection
of appropriate domains and measures of neurobehavior, and data safety and monitoring. Here we
summarize instruments for the assessment of the neonate, infant, and child that are being employed
in the Centers for Children’s Environmental Health and Disease Prevention Research, sponsored
by the National Institute of Environmental Health Sciences and the U.S. Environmental Protection
Agency, discuss neural and neurobiologic measures of development, and consider the promises of
gene–environment studies. The vulnerability of the human central nervous system to environmen-
tal chemicals has been well established, but the contribution these exposures may make to prob-
lems such as attention deficit disorder, conduct problems, pervasive developmental disorder, or
autism spectrum disorder remain uncertain. Large-scale studies such as the National Children’s
Study may provide some important clues. The human neurodevelopmental phenotype will be
most clearly represented in models that include environmental chemical exposures, the social
milieu, and complex human genetic characteristics that we are just beginning to understand.
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long-term prospective longitudinal studies of
cohorts recruited prenatally or at birth as the
optimal design to ascertain neurobehavioral
deﬁcits in relation to exposure to environmen-
tal chemicals (Krasnegor et al. 1994). The lit-
erature on lead provides a model example of
early exposure associated with higher-order
neuropsychological and behavioral dysfunc-
tions in older children and adolescents (e.g.,
Bellinger et al. 1992; Burns et al. 1999;
Needleman et al. 1990; Tong et al. 1996).
Long-term neurodevelopmental consequences
have also been observed in a cohort study of
children exposed in utero to PCBs (Jacobson
and Jacobson 1996, 2003). Evaluations at ear-
lier ages can and have revealed changes in cog-
nitive function, but these may be less robust
and deﬁnitive (Dietrich and Bellinger 1994).
Biologic plausibility. A number of factors
determine the transplacental passage of envi-
ronmental contaminants (Wilson 1977).
Toxicants with low molecular weight, lipid
afﬁnity, nonpolarity, and low protein binding
properties cross the placenta with ease (Slikker
and Miller 1994). Unfortunately, most com-
pounds possess one or more of these proper-
ties, cross the placenta, and enter the fetal
circulation (Beckman and Brent 1999).
The immature blood–brain barrier of the
fetus and young infant is more permeable to
xenobiotics, and the fetus lacks drug-metabo-
lizing detoxiﬁcation capacities that are present
postnatally (Rozman and Klaassen 1996).
The chemical properties of certain toxicants
also determine access to brain tissues. Lead
imitates calcium ions and therefore crosses the
blood–brain barrier with relative ease (Kerper
and Hinkle 1997). In the blood stream,
methylmercury combines with cysteine, form-
ing a compound that is structurally similar
to the essential amino acid methionine.
This methylmercury–cysteine compound is
actively transported into the endothelial cells
in the blood–brain barrier on the methionine
carrier and ultimately into the brain on a
glutathione carrier (Kerper et al. 1992). The
chlorobiphenyls and several classes of pesti-
cides also gain access to brain tissues by virtue
of their lipid solubility.
Toxicants linked with growth retardation
and maturational delays in utero should be
considered prime candidates for functional
developmental toxicity. Any compound that
retards intrauterine somatic growth should be
examined as a potential neurobehavioral ter-
atogen (Wilson 1977). Low-level intrauterine
exposure to lead, PCBs, and organophosphate
pesticides has been associated with lower birth
weight, gestational maturity, or reduced head
circumference in some prospective studies
(e.g., Berkowitz et al. 2004; Dietrich et al.
1987; Eskenazi et al. 2004; Fein et al. 1984;
McMichael et al. 1986; Whyatt et al. 2004).
Because of their potential disruption of
central nervous system morphoregulation,
hormonally active agents should also be con-
sidered as candidate neurodevelopmental
toxicants. Hydroxylated metabolites of PCBs
and related compounds may bind to human
transthyretin, the only thyroid-hormone–
binding protein synthesized in the brain.
By binding to transthyretin, some hydroxy-
lated PCBs may alter brain free thyroxine
(T4) levels and interfere with central nervous
system development and function (Cheek
et al. 1999; Seegal 2000). Recent evidence
also suggests that PCBs up-regulate several
thyroid-hormone–responsive genes that are
expressed during periods of brain develop-
ment (Gauger et al. 2004).
Environmental chemicals with excitatory
effects on neurons (prolonged depolarization)
are potential developmental neurotoxicants, as
well. Examples include nicotine, the organo-
phosphate and carbamate pesticides (Slotkin
1999), and some metals, including lead
(Bressler et al. 1999).
Population factors. Population factors
encompass a host of variables that affect a
study’s design, plan of execution, and sensitivity
to the potentially adverse neurodevelopmental
consequences of exposure to environmental
toxicants. Several sometimes highly intercorre-
lated co-factors are involved, such as socio-
economic status, ethnicity, nutrition, access to
medical care and educational resources, lan-
guage spoken in the home, and cultural milieu.
These variables will need to be considered when
devising recruitment and long-term retention
strategies, and especially when selecting the
most appropriate methods of neurodevelop-
mental assessment. The ﬁeld of neurobehavioral
testing has been at the center of this dilemma as
psychologists have struggled with the problem
of how to design tests that do not measure only
culturally specific information that is quite
familiar to children from certain groups or
social backgrounds but less familiar to those
from different backgrounds. Investigators can
use tests that have been adapted for non-
English-speaking children and their families.
In the United States, this typically involves
Spanish translations of extant instruments (e.g.,
intelligence or speech, language, and memory
tests), but the inventory of instruments in
Spanish is still quite low. Furthermore, different
dialects within the U.S. Spanish-speaking pop-
ulation exist, thus adding another complication.
For example, the Children’s Centers at the
University of California at Berkeley, Columbia
University, and Mount Sinai School of
Medicine had Spanish-speaking populations
from Puerto Rico, Mexico, and Dominican
Republic with different regional dialects. In
these cases, it is important to ask the caregiver
what language is spoken in the home. All assess-
ments of non-English–speaking children should
be done by examiners who are bilingual, prefer-
ably with the language of concern (e.g.,
Spanish) as their native tongue. Piloting of pre-
viously translated tests in the population of
interest is always essential to determine their
suitability. Some nonverbal tests have been con-
sidered to be culturally neutral, such as the
Raven’s Progressive Matrices (Raven 1998).
However, even nonverbal tests may not be
completely culturally neutral if the skills needed
to complete the task are outside of the cultural
experience of the population being evaluated.
One solution to this problem may lie in
the use of so-called culture-neutral electro-
physiologic, operant learning, or classical con-
ditioning protocols. These types of tests also
have the advantage that parallel animal tests
that assess the same or similar functional
domains are available. The drawback of using
these “culture-fair” procedures is that the
functional signiﬁcance of any ﬁnding is some-
times difﬁcult to calculate.
The degree of confounding can also vary
greatly from one population to another and
significantly affect a study’s ability to detect
associations between toxicant exposures and
various parameters of neurodevelopment. In
some populations, the degree of confounding
may be so great that, after statistical adjust-
ment, the exposure variable(s) no longer
accounts for any further unique (indepen-
dent) variance in the neurobehavioral data.
Lead is a model example where exposure is
typically correlated with other suboptimal
environmental and sociohereditary factors
(e.g., Dietrich et al. 1991). In such cases, any
additional attributable developmental risk,
beyond that accounted for by confounders, is
obscured. This raises the specter of type II
error (Needleman and Bellinger 1986).
The problem of confounding is not limited
to correlations between a chemical exposure
and nonchemical covariables such as socio-
economic status, quality of child rearing, and
parental intelligence, among others. In some
cases, populations can be exposed to a mixture
of compounds that are also intercorrelated.
This presents a conceptual and biostatistical
challenge when attempting to estimate the
independent or combined additive or synergis-
tic effects of multiple chemical exposures
(Jacobson 2001). For example, critical reviews
of the Faroe Islands study of methylmercury
and child development have suggested that the
effects attributed to intrauterine exposure to
methylmercury might be the consequence of
co-exposures to high levels of PCBs [Myers
and Davidson 2000; Toxicology Excellence for
Risk Assessment (TERA) 1999]. Most other
investigations of neurotoxicants in humans
have not measured a multitude of exposures
but have examined the behavioral toxicity of
single toxicants. With the advent of more sen-
sitive biomarkers of environmental exposures,
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Children’s Centers and in the National
Children’s Study will be facing a new challenge
of developing both statistical and toxicologic
methods for addressing the impact of multiple
exposures. The importance of this has been
shown in a recent study in animals demon-
strating that the effect of the organophosphate
chlorpyrifos was exacerbated by the pharma-
ceutical agent terbutaline commonly used to
prevent preterm delivery (Rhodes et al. 2004).
The problem of confounding in environ-
mental neuroepidemiology has led some to
speculate about the advantages of studying
chemical or drug exposures in lower risk pop-
ulations for the purpose of reducing con-
founding and thus strengthening associations
between measures of dose and disease (e.g.,
Bellinger 1995). However, restricting neuro-
behavioral studies of environmental toxicants
to lower risk populations is not without sci-
entiﬁc and ethical drawbacks. U.S. citizens at
the lowest levels of social strata tend to suffer
the greatest toxic burden. Furthermore, the
opportunity to assess the interactions of toxi-
cant exposures with other risk factors may
be missed. The effects of prenatal and early
postnatal exposure to developmental neuro-
toxicants may be more severe among the dis-
advantaged, where nutritional deficiencies,
lack of adequate prenatal care, and subopti-
mal psychosocial environmental factors are
likely to be more common.
Site factors. Examiners are often compelled
to conduct assessments under less than ideal
conditions. Inadequate space, lighting, excess
ambient noise, and other distractions can
invalidate even the most carefully administered
protocol. The developmental assessment of an
infant or child should be regarded as a con-
trolled experiment, just as in animal models
involving behavioral measures.
For neonates and infants, it is especially
critical that the clinic environment is con-
ducive to a valid test. For the newborn, light-
ing, temperature, noise, and any other factors
that affect the neonate’s state can determine
the validity of the test. For an infant or child of
any age, a comfortable, quiet, and well-lighted
testing environment is a minimal requirement.
Furniture, including chairs and table, should
be appropriate for the test and developmental
stage of the child. Test materials should be out
of the child’s sight but still easily accessible to
the examiner to avoid fumbling and other mis-
cues. Infants and some preschool children will
often need the security and support of a care-
giver during the examination, so accommoda-
tions should be made to have another adult in
the room, seated in an area where the subject
will not be distracted.
In some studies the geographic dispersion
of the population may make home or school
place testing the only practical option. Indeed,
testing sometimes must take place in multiple
sites to accommodate families and prevent loss
to follow-up. For example, studies in large
rural communities (e.g., the Berkeley study of
children in the Salinas Valley community) ﬁnd
it necessary to use a recreational vehicle in
addition to the clinic site to reach families
without any means of transportation and to
avoid distractions within the home.
Child factors. It would seem obvious that
the infant or child should be in an appropri-
ate state or physical condition for assessment.
However, this factor is not always given the
consideration it deserves. The child should be
reasonably well when evaluated with no
current infection that is likely to signiﬁcantly
affect performance such as a severe upper
respiratory infection or acute otitis media.
Any medications the child may be on should
also be recorded. It is important to clarify this
with the parent before the assessment begins.
A child who is too ill to respond appropriately
to the demands of the examination should be
rescheduled.
Given that many neurodevelopmental test-
ing procedures require normal sensory func-
tion, a vision and hearing screen should also
precede the examination. In some studies,
sensory functions may be core outcome vari-
ables. In this case, a more detailed assessment
of vision (farsightedness, depth perception,
color perception, acuity/contrast sensitivity)
and hearing (tympanometry, pure-tone audi-
ometry, central auditory processing) will be
indicated. Assessment of audition can be con-
ducted as early as 6 months using methods
such as visual reinforcement play audiometry.
The auditory brainstem response (ABR) can
also be employed to noninvasively measure the
electrophysiologic responses of the brainstem
auditory pathways (Roizen 1996). The auto-
mated ABR is already a routine procedure for
screening neonates for hearing problems in a
large number of hospitals in the United States,
although a program of universal screening has
not been implemented [American Academy of
Pediatrics (AAP) 1995]. Methods for assessing
refractive errors and amblyopia in infants and
young children with limited verbal abilities
such as the Allen cards and Snellen chart can
also be used. However, in the toddler and pre-
schooler, observing the child’s response to visu-
ally engaging stimuli of various sizes can be just
as valuable as a screening tool (Hoon 1996).
These neurosensory data can be used as
core outcomes (i.e., if the toxicant in question
is expected to affect vision or hearing), as
effect modifiers (i.e., a toxicant’s effects on
tasks involving visual or auditory processing
may be more pronounced among youngsters
with preexisting deﬁcits in these areas), or as
potential confounders. However, extreme care
must be taken when using such data as con-
founding or control variables. If deficits in
neurosensory function are an expression of
exposure to the toxicant(s) in question, the
resulting overcontrol may lead to a false nega-
tive ﬁnding or type II error.
Some way of rating the child’s behavior
and affect during the test session is also desir-
able. The child’s response to examiner and test
situation, attitude toward self and test perfor-
mance, work habits and problem-solving style,
motor functioning, visual and auditory acuity,
oral communication, and mood are some of
the factors that could potentially affect perfor-
mance and should be noted. These data can
be entertained as co-factors in outcome analy-
ses, but this may lead to overcontrol. Indeed,
behavioral disturbances that are rated by the
examiner as limiting the validity of the exami-
nation can also be considered as legitimate
behavioral sequelae of exposure.
Another factor that can affect a child’s per-
formance is the presence of a parent. A parent
provides physical and emotional support for
an infant or toddler but can also be a source of
disruptive inﬂuences on the child’s responses.
Although the presence of a familiar caregiver
is necessary and desirable for assessment of
infants < 2 years of age, the parent or other
caretaker should be instructed not to interfere
with the presentation of stimulus materials,
examiner instructions, or the child’s behaviors
during the test. By the later preschool years,
the parent should be encouraged to not be
present during the examination. If a child
absolutely needs the security of a familiar care-
giver, the examiner should seat the adult com-
panion outside of the child’s ﬁeld of vision.
Quality assurance and quality control.
Analytical laboratories go to great lengths to
assure the validity and reliability of their
assessments of toxicants in environmental
samples and biologic tissues with quality assur-
ance and quality control protocols. Similar
issues are germane to neurodevelopmental
assessment. Results of individually adminis-
tered behavioral assessments depend to a great
degree on the interaction between the child
and examiner. Therefore, it is imperative that
the examiner’s contribution be equivalent for
all children so that interchild differences in
performance can be attributed to child charac-
teristics rather than to some combination of
child and examiner characteristics.
Although not always easy to achieve, the
following recommendations apply to any lon-
gitudinal prospective study of the effects of
neurodevelopmental toxicants. Ideally a single
examiner should be used at each site or center.
The examiner should be well seasoned and
familiar with the population of interest. It is
not necessary for a doctoral-level psychologist
to administer most tests that are likely to be
used in these studies (Brandt and van Gorp
1999). Individuals with baccalaureate or mas-
ter degrees in psychology or related ﬁelds with
Lessons learned for neurodevelopmental assessment
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istration and scoring of neuropsychological
tests can examine children enrolled in a study,
under professional supervision [American
Academy of Clinical Neuropsychology
(AACN) 1999]. The examiner should be
blinded to the group membership or exposure
status of the child. Children from high-,
medium-, and low-level exposure groups (if
known) should be tested in a randomly inter-
mixed order. If more than one examiner
is used, their comparability in training and
technique should be explicitly checked and
regularly monitored. In multicenter studies,
examiner training should be standardized
across sites and regular meetings, and confer-
ence calls should be arranged to discuss issues
of administration and scoring as they arise.
Dietrich and Bellinger (1994) cite an
example of the difﬁculties that can arise when
the second and last guidelines are neglected.
In a study of lead-exposed children, the aver-
age IQ scores assessed by two relatively inex-
perienced examiners differed by more than
one standard deviation or 15 points (Gregory
et al. 1976).
In long-term prospective studies, it is not
always possible to rely on a single experienced
examiner to test all children. Attrition of staff
and requirements for backup psychometricians
in the event of leave usually require that a
research center employ the services of two or
more examiners. Interexaminer differences can
be minimized by having the same developmen-
tal neuropsychologist train them and by video-
taping practice administration sessions to
provide feedback to the trainee and assess the
presence of any differences in adherence to
standardized administration or style that may
result in interexaminer variability and measure-
ment error. Videotaping can also provide the
opportunity to assess interexaminer reliability
in scoring the protocols (Chandlee et al. 2002).
In studies spanning several years, monitoring
of interexaminer reliability and proficiency
should be practiced at regular intervals. This is
particularly critical for multicenter studies
employing identical neurodevelopmental
assessment protocols. Whether one or several
examiners are active at a given site, it is impera-
tive that their reliability and proficiency be
monitored over the entire course of the study
to prevent any drift away from standardized
procedures for administration and scoring.
All studies should carefully document
quality assurance and control procedures and
report intertester and interscorer reliability
coefficients where appropriate. As Bellinger
(2002) has noted, “the expectations for report-
ing the reliability of these [neurobehavioral]
measurements should be no different from the
expectations for reporting exposure (i.e., bio-
marker) measurements such as hair-mercury
or blood-lead levels.”
Nevertheless, although the Children’s
Centers instituted quality control protocols,
particularly for the neurodevelopmental
assessments, including direct observations or
videotaping, insufficient time and resources
made it difficult to fully meet the goals of
these quality control programs. In our experi-
ence, the effort and cost associated with this
are frequently underestimated. The National
Children’s Study needs to make every effort
not to fall short in this critical area.
Sensitivity and speciﬁcity of neurodevelop-
mental measures. The terms “sensitivity” and
“specificity” have two different meanings in
the context of this article. In the evaluation of
diagnostic tests, the sensitivity of a measure is
deﬁned as the proportion with the abnormal-
ity that the test classiﬁes as abnormal (i.e., the
proportion of true positives), whereas the
“speciﬁcity” is the proportion of normal that
the test classifies as normal (i.e., the propor-
tion of true negatives). In the selection of neu-
rodevelopmental measures for environmental
studies, it is clearly advantageous to include
tests that have the best possible prognostic
value. This is particularly critical if neurobe-
havioral end points are incorporated into risk
assessments conducted by regulatory bodies
(Bellinger 2002). However, in this context we
are also concerned with the selection of instru-
ments that tap into neurodevelopmental
domains that have been shown to be sensitive
to (affected by) exposure to particular environ-
mental toxicants. Of course, this assumes that
some information already exists as to the
effects of a given compound on the developing
nervous system. Sometimes there are no prior
human studies available to help dictate the
domains that should be examined, and animal
studies may not include domains that are
unique to human cognition (e.g., language).
In cases where there are multiple potential
exposures with different mechanisms or loci of
effect or when the exact exposures are not
known or hypothesized, it may be necessary to
use a broad spectrum of assessment tools.
However, to the extent such information is
available, selection of tests can be based on
hypothesis-based inference. Under these cir-
cumstances, the focus shifts from “selecting
tests” to the nomination of neurobehavioral
domains to tap and subsequently to the
employment of the best available measures
(Bernstein 1994).
A wide range of neurobehavioral assess-
ments has proven to be sensitive to lower level
prenatal and early postnatal exposures to envi-
ronmental contaminants, for example, lead,
methylmercury, PCBs, environmental tobacco
smoke, and other chemicals. However, the
identiﬁcation of behavioral phenotypes for spe-
cific agents has been an elusive goal. Some
attempts have been made to differentiate the
effects of alcohol exposure in utero from
deﬁcits in neurobehavior associated with PCBs
and other toxicants [e.g., Jacobson 1998;
National Institute on Drug Abuse (NIDA)
2000]. However, environmental studies have
failed to clearly identify a “behavioral signa-
ture” for particular compounds. The best evi-
dence for speciﬁc effects probably comes from
the literature on PCBs, where deﬁcits in cog-
nitive processing involving visual discrimina-
tion and memory appear to be a somewhat
consistent finding in exposed infants and
preschool children (Darvill et al. 2000;
Jacobson et al. 1992). However, toxicants such
as lead, methylmercury, and even the chloro-
biphenyls seem to affect a wide range of neuro-
behavioral outcomes without illustrating a
convincing degree of consistency across
domains from one study to another. The sam-
ple’s socioeconomic status; level, pattern, and
timing of exposures; nutritional intake; general
health; educational opportunities; and the par-
ticular instruments that were employed to
examine neurodevelopment probably play an
important role in between-study differences
(Bellinger 1995; Schantz 1996). This could
explain why the wide net provided by global
and multiple-domain assessments of cognitive
development such as IQ have proven to be so
consistently sensitive across studies. Because
these tests combine subscales that are represen-
tative of a broad number of underlying cog-
nitive functions, they are likely to pick up
exposure-related deﬁcits across cohorts that dif-
fer in their functional expressions of toxicity.
However, despite the sensitivity of these tests,
their use in environmental studies has been
sharply criticized by some reviewers. Critics of
these apical measures note that they cannot
readily yield information about the affected
neural substrates or the complex executive and
regulatory processes involved in learning, prob-
lem solving, and behavior (Bernstein 1994;
Krasnegor et al. 1994; White et al. 1994).
Furthermore, although global measures of
intellectual functioning have proven to be sen-
sitive measures of exposure to a number of
environmental chemicals, this has not been the
case for prenatal exposure to alcohol or drugs
(NIDA 2000).
Data safety and monitoring. There is an
ethical responsibility that referral protocols be
in place to deal with the needs of children who
perform poorly in the course of their partici-
pation in the study. Criteria need to be estab-
lished for referral before data collection begins.
Because of the sensitivity of certain tests, only
performance on some may result in referral.
Also, because of the predictive validity of these
tests, a more rigorous criterion may be used at
older ages (e.g., scores three standard devia-
tions below the mean up to 24 months and
2 standard deviations afterward). Referrals
normally take place through the primary care
provider with parental permission. All referral
Dietrich et al.
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Constructing a battery of tests for an environ-
mental study of developmental neurotoxicants
can be a daunting task. First, the investigator
is faced with choosing from a large number of
potential end points that can be measured in a
prospective study of any given agent or mix-
ture of compounds to which the fetus or child
may be exposed. Domains of interest in stud-
ies of this kind include overall neurologic sta-
tus, sensorimotor skills, attention, memory,
problem solving (executive functions, organi-
zation, and planning), visual–spatial and per-
ceptual skills, speech and language abilities,
behavioral problems, and adaptive skills as
well as more global indices of intellectual
attainment and academic achievement.
Ideally, as stated above, the choice of neuro-
behavioral domains and the tests used to index
them should be determined by what is known
about the impact of a particular environmen-
tal agent on the development of speciﬁc cogni-
tive, neuromotor, and behavioral features.
However, as previously discussed, this is not
always easily accomplished because of the lack
of evidence for speciﬁc behavioral phenotypes.
In this regard, animal studies have potential
for identifying key functional domains that are
affected by exposure and would be relevant to
assess in human populations. For example, the
Children’s Center at the University of Illinois
is using studies in animals exposed to PCBs
and methylmercury during gestation to iden-
tify speciﬁc aspects of cognitive, sensory, and
motor functions that are affected by combined
exposures. These data will be used to guide the
assessment of children in a companion cohort
study.
Ultimately, the best strategy is to develop a
battery that includes both broad-based meas-
ures of cognitive and neuromotor status as
well as more ﬁne-grained assessments of spe-
cific skills. Narrow-band instruments should
target domains that, based on the extant
human and animal literature, are believed to
be affected by exposure to the toxicant(s) in
question (e.g., for hypothesis-based battery
development from the perspective of child-
hood lead poisoning, see Dietrich et al. 2004;
Rogan et al. 2001).
A second consideration in battery develop-
ment is the amount of time that can be allo-
cated to the assessment. The energy and
attention spans of younger subjects are rapidly
exhausted, calling for shorter periods of time
for testing, more frequent breaks, and some-
times multiple appointments separated by days
or weeks. Infants < 1 year of age can usually
tolerate only about 45 min of standardized
testing, whereas a 2-year-old can generally
perform adequately over a period of roughly
75 min. For preschool and older children,
breaks for a snack or just relaxing with the
primary caregiver can fortify the child’s endur-
ance. Furthermore, neurodevelopmental evalu-
ations are often part of a larger protocol that
includes collection of sociodemographic infor-
mation from parents, a general medical evalua-
tion of the child, and collection of biologic
specimens such as blood, hair, and urine.
Retention of children and their families in a
long-term study can be compromised if the
demands on their time and effort are excessive.
Unique Considerations for
Assessment of the Neonate,
Infant, and Child
The neonate. The neonatal period extends from
birth to roughly 1 month of age. Assessment
of the neonate can be used to evaluate gesta-
tional maturity, neurologic status, and behav-
ioral style and capacities. Neonatal assessment is
a highly specialized area requiring continuous
and careful attention to the infant’s state as the
examination proceeds. Recognized infant states
include several sleep states, drowsiness or transi-
tional states, alert states, and crying. Reﬂexes
and muscle tone, signs of stress, and alertness
and orientation can all be affected by the
newborn’s state.
Although neonatal neurodevelopmental
assessments are not highly predictive of later
functioning, performing a neurologic and
neurobehavioral assessment after birth pro-
vides an assessment of the immediate effects of
prenatal exposure before any inﬂuences of the
extrauterine environment take place. A repeat
exam (i.e., 2 or 4 weeks) allows assessment of
neurobehavior after infants have stabilized.
Inclusion of both assessment time points may
provide insight into those effects of prenatal
exposure that are transient and those that per-
sist (Jacobson et al. 1984; Stewart et al. 2000).
Neonatal assessment places special demands
on quality control and site. Some instruments
such as the Neonatal Behavioral Assessment
Scale (NBAS) (Brazelton 1984; Brazelton and
Nugent 1995) and the Neonatal Intensive
Care Unit (NICU) Network Neurobehavioral
Scale (Lester et al. 2004) require intensive
training of examiners to master the techniques
of administration and become reliable in scor-
ing newborn responses. Training may demand
travel to institutions with certification pro-
grams (for further details, see Brown Medical
School Infant Development Center 2005).
Each investigator will have to determine if
these essential preconditions for neonatal neu-
robehavioral assessment can be met. The
assessment of the neurologic and neurobehav-
ioral status of the newborn will not usually be
a practical option in studies involving popula-
tions that are widely dispersed geographically
or living in communities lacking the required
clinical facilities or trained and certified
personnel.
The infant and toddler. Infants and tod-
dlers between 6 and 36 months of age may be
the most challenging population for obtaining
systematic and reliable behavioral data using
paradigms that require the child to sustain
attention, follow directions, and direct their
cognitive effort toward a task that requires
adherence to a somewhat rigid protocol.
Although the cognitive capacities of older
infants and toddlers are much advanced com-
pared with their prelinguistic and prelocomo-
tor days, directing that cognitive capacity at
any particular time is often the most challeng-
ing part of the assessment. The clinical skills
of the person examining the infant and tod-
dler are of paramount importance for obtain-
ing data that are valid and reliable.
Indices of neurodevelopment in infants
and toddlers are less stable over time and, at
least before 24 months, lack substantial pre-
dictive validity for later morbidity. This is
partly because of the means by which infants
are able to express their cognitive abilities
(i.e., primarily through sensorimotor acts) and
the lack of continuity in response modalities
from infancy to older childhood and ado-
lescence. However, neurobehavioral test scores
in infancy retain strong concurrent validity.
Bellinger (2002) suggests that scores on infant
neurodevelopmental measures can be under-
stood in a manner analogous to the neonatolo-
gist’s interpretation of birth weight. Except in
very low-birth-weight infants, weight at birth is
not predictive of later weight, although birth
weight is a very informative index of a new-
born’s general health status. Also, as with
neonatal measures, the time between neurotox-
icant exposure in utero and postnatally and the
assessment of outcome is reduced. Thus, the
inﬂuence of later intervening and potentially
confounding factors is diminished along with
increased strength and reduced bias in the esti-
mate of the neurotoxicant’s contributions to
development (Bellinger 2002). Furthermore,
where neurotoxicants such as lead, PCBs, and
methylmercury have predicted poorer perfor-
mance in infants and preschoolers, forward
studies have demonstrated that functional
deficits in neurobehavior persist into later
childhood (Dietrich 2000).
Older preschoolers and school-age children.
Because of the greater social maturity, auto-
nomic stability, and endurance of the older
preschool and school-age child, substantially
more time can be devoted to a single assessment
session. Also, owing to the tremendous growth
in the range and clarity of a child’s response
capabilities, assessments of preschoolers and
older children generate a more differentiated
picture of a subject’s developmental strengths
and weaknesses. Functional impairments
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To investigate the developmental effects asso-
ciated with exposure to neurotoxicants in the
fullness of time, studies should maintain fol-
low-up at least until children attain school
age. Indeed, recent studies of the long-term
sequelae of early lead exposure would suggest
follow-up to adolescence and young adult-
hood is necessary to reveal the full range of
exposure related morbidities. There are a
number of reasons for extending follow-up
into late childhood and adolescence. Deﬁcits
still apparent at later ages are generally
thought to be of greater practical signiﬁcance
because the predictive validity or prognostic
value of later preschool and school-age perfor-
mance is considerably greater than that of
performance in infancy, thus providing a
sounder basis for drawing inferences about
the long-term effects of prenatal or early post-
natal exposures.
Neurodevelopmental
Assessment at the Children’s
Centers
Neurodevelopmental assessment practices in
the longitudinal birth cohort studies at the
Children’s Centers were guided by many of
the principles outlined above. Most centers
conducted neurodevelopmental assessments
at various ages after birth (see Table 1). For
the first 5 years of funding, most centers
conducted assessments at 12 months and
24 months of age.
A diverse group of standardized neurode-
velopmental assessment tools were employed.
There were no attempts to develop common
protocols among the centers conducting
neuroepidemiologic studies. Differences in
tests and timing of assessment reflect varia-
tions in the toxicants under study, their
hypothesized effects, and practical considera-
tions. Four centers conducted neonatal assess-
ments; three used the NBAS (Brazelton 1984;
Brazelton and Nugent 1995), and one used
the NICU Network Neurobehavioral Scale
(Lester et al. 2004). The Bayley Scales of
Infant Development–II (Bayley 1993), which
provides standard scores for mental and
psychomotor development, were used by all
centers at 12 months of age and by most at
24 months. All centers adjusted the child’s
chronologic age for prematurity on the Bayley
scales until 24 months.
A variety of other assessment tools were
used to measure domains including develop-
mental milestones, language, and behavior. A
few centers employed more experimental pro-
tocols, including assessment of visual recogni-
tion memory, the autonomic nervous system,
and measures of learning that parallel some of
those used in animal studies. The centers at
Illinois and the University of Cincinnati also
assess the child’s hearing.
The choice of neurodevelopmental tests
was based first on the age of the child, fol-
lowed by other considerations including tests
employed in previous studies, the domains of
behavior thought to be affected by the main
toxicant(s) under study, the availability of tests
in the language of the study population, time
required to administer the examination, and
the test’s suitability for administration by non-
doctoral-level examiners. Some centers, espe-
cially those with low-income or bilingual study
populations, found it necessary to select assess-
ment tools with a lower end of functioning
range, considerably below the ages of the chil-
dren being assessed.
As discussed above, it can be difficult
to determine the language of assessment for
Dietrich et al.
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Table 1. Neurodevelopmental assessment in the Children’s Centers for the ﬁrst 5-year funding cycle.
University of University of Columbia Mount Sinai University of
Assessment tool Illinois California, Berkeley University Medical Center Cincinnati
Neonatal assessment tools
Brazelton (Brazelton and Nugent 1995) Birth Birth Birth
Ballard (Ballard et al. 1991) Birth
NICU Network Neurobehavioral Scale Birth, 4 weeks
(Lester et al. 2004)
Infant and toddler assessment tools
Bayley scales (Bayley 1993) 6, 12 months 6, 12, 24 months 12, 24, 36 months 12, 24a months 12, 24 months
PLS (Zimmerman et al. 1992) 6, 12, 24 months
CBCL (Achenbach and Rescorla 2004) 12, 24 months
Denver (Frankenburg et al. 1992) 6 months
Fagan (Fagan et al. 1986) 6 months 6 months
Infant Behavior Questionnaire (Rothbart 1981) 12 months
Toddler Behavior Assessment Questionnaire 24a months
(Goldsmith 1996)
Sleep questionnaire (adapted from Morrell 1999) 6, 12, 18, 23 months
Cognitive tasksb(Aguiar and Baillargeon 1999) 6, 9, 12 months
Child assessment tools
WPPSI-III (Wechsler 2002) 42c months 60 months
NEPSY (Korkman et al. 1998) 42c months
McCarthy (McCarthy 1974) 42c months
CBCL (Achenbach and Rescorla 2004) 42c months
Other child assessments
Auditory assessment Birth, 12 months
Autonomic Nervous System Assessment 6, 12, 42c months
(Alkon et al. 2003)
HOME Scale (Caldwell and Bradley 1984) 6, 12, 24, 42c months 36 months 12, 24 months 12 months
Maternal intelligence
PPVT (Dunn and Dunn 1981)/TVIP (Dunn et al. 1986) 6 months Pregnancy
WASI (Wechsler 1999) 12 months
TONI-2 (Brown et al. 1990) 24 or 36 months
WAIS-III (Wechsler 1997) Enrollment 6 months (matrices)
(matrices and
block design)
Abbreviations: CBCL, Child Behavior Checklist; HOME, Home Observation for Measurement of the Environment; NEPSY, A Developmental Neuropsychological Assessment; PLS,
Preschool Language Scale; PPVT, Peabody Picture Vocabulary Test; TONI-2, Test of Nonverbal Intelligence-2; TVIP, Test de Vocabulario en Imagenes Peabody; WAIS-III, Wechsler
Adult Intelligence Scale-III; WASI, Wechsler Abbreviated Scales of Intelligence; WPPSI-III, Wechsler Preschool and Primary Scales of Intelligence-III.
aChildren were brought in up to 5 years of age for the “24-month” assessment; if too old for the Bayley, they were assessed with the Batelle Developmental Inventory (Newborg et al.
1984). bThis consists of object retrieval tasks that examine working memory, executive control, and cognitive development. cCurrently underway as part of second 5-year funding cycle.children who are raised in the United States in
non-English-speaking households. All centers
attempted to maximize the child’s perfor-
mance on all tests. One center assessed bilin-
gual children in English. Another center based
the child’s assessment on what language was
usually spoken in the home. In both cases, if
the examiner noted language difﬁculties dur-
ing the exam, the tasks were readministered in
the other language.
The availability of assessment tools
increases with the child’s age, enhancing the
researcher’s ability to focus on speciﬁc devel-
opmental domains that may be affected by
the exposure of interest. Because many of the
chemicals examined by these centers have not
been widely studied in children (e.g., pesti-
cides, polycyclic aromatic hydrocarbons), the
choice of the domains likely to be affected
may be based solely on animal studies.
Finding the human analog to animal behavior
is challenging. However, as previously noted,
the Illinois center is addressing this problem
by conducting concurrent animal studies with
exposures similar to those in their human
population.
All centers used some quantitative meas-
ures of the parent’s cognitive functioning and
quality of caregiving in the home to control
for possible confounding. In centers dealing
mainly with multicultural samples, tests of
adult intellectual attainment with a minimum
of verbal content were used.
Future Directions for
Neurodevelopmental
Assessments in the National
Children’s Study
New technologies for assessment of the func-
tion and structure of the central nervous sys-
tem may hold promise for advancing our
understanding of the impact of environmental
chemicals on neurodevelopment. Some of
these are brieﬂy discussed below.
Computer-based experimental measures for
children. Numerous attempts have been made
to develop computer-administered batteries of
tests for children exposed to environmental
neurotoxicants. For example, adaptations of
the Neurobehavioral Evaluation System
(Baker et al. 1985) have been used in studies
of children exposed to heavy metals in both
the United States and abroad (Dahl et al.
1996). A computer-assisted comprehensive
assessment for children enrolled in environ-
mental studies has been developed by Anger
and colleagues (Rohlman et al. 2003). The
Behavioral Assessment and Research System
has been designed for use in studies of chil-
dren as young as 3 years of age and has been
adapted for use with Hispanic populations
(Rohlman et al. 2001). The entire battery
consists of 11 computer-administered tests
assessing sustained and selective attention,
working memory, motivation, new learning,
response speed, executive functions, and ﬁne-
motor coordination.
The use of computer-assisted tests has sev-
eral advantages in that examiner effects are
reduced and data collection and scoring are
automated and objective. However, care must
be exercised when applying these methods to
populations that have little or no exposure to
computers or similar kinds of automated sys-
tems. Another potential drawback of com-
puter-assisted tasks is that they can minimize
interaction with a friendly, supportive exam-
iner, which can be essential in helping keep the
younger child motivated to complete a lengthy
battery of tests. If computer-assisted tests are
used, it may be best to intersperse them with
examiner-administered tasks.
Psychobiologic measures. Studies of young
children have included many psychosocial,
environmental, and neurodevelopmental fac-
tors, but they rarely include individual dif-
ference measures of psychobiology. Recent
studies show that children’s physiologic
responses to different stressors are valid meas-
ures of individual psychobiology or autonomic
reactivity (Alkon et al. 2003; Matthews et al.
1990). These psychobiology measures have
been shown to affect how children interact with
their family, adults, and peers at home and in
school. In addition, children’s psychobiology is
related to their physical and mental health
(Boyce et al. 1998; Kagan et al. 1988; Porges
et al. 1994). Autonomic reactivity is being
studied as an outcome of organophosphate
exposure prenatally and postnatally at the
Berkeley Children’s Center. Autonomic dysreg-
ulation or an imbalance in the parasympathetic
and sympathetic branches of the autonomic
nervous system may be a sensitive indicator of
acute and chronic pesticide exposure (Eskenazi
et al. 1999). The Columbia center is using the
orthostatic tilt test (Fifer et al. 1999) on a small
subsample in the cohort. This is a noninvasive
experimental paradigm used to identify infants
with individual differences in autonomic regu-
lation and diminished physiologic responses
(as measured by heart rate) to blood pressure
changes after postural adjustment.
Neurobiologically based markers of develop-
ment. Several environmental studies of children
have used electrophysiologic techniques to
assess the effects of neurotoxicants on central
nervous system function. Visual as well as audi-
tory evoked potentials have been examined and
in many cases have been found to be sensitive
to environmental chemical exposures. Another
promising area for the future is the use of neu-
roradiologic techniques such as magnetic reso-
nance imaging (MRI). MRI assessment of brain
structure and function is beginning to be used
in studies of developmental neurotoxicants.
In the Cincinnati center, for example, adults
exposed to high levels of lead in early childhood
are being examined using volumetric, func-
tional, and spectroscopic MRI methods. These
methods provide data on exposure-related
structural changes, brain activation in response
to standardized verbal and visual–spatial prob-
lems, and brain biochemical processes.
The use of these methods assumes the
availability of a clinical facility that can provide
the needed equipment and trained personnel.
For many centers, particularly those far from
large metropolitan areas, this will normally not
be an option.
Gene–environment interactions in neuro-
development. A promising area for future
study is the interaction between certain
genetic polymorphisms involved in neuro-
transmitter regulation and metabolism with
environmental chemical exposures. For exam-
ple, the Cincinnati center has examined the
joint effects of a dopamine transporter (DAT)
polymorphism and maternal prenatal smoking
on childhood hyperactivity-impulsivity and
inattentiveness (Kahn et al. 2003). Childhood
hyperactivity–impulsivity and oppositional
behaviors were associated with a DAT poly-
morphism, but only when the child also had
in utero exposure to the products of maternal
smoking. Cincinnati researchers have also iden-
tiﬁed a vitamin D receptor gene polymorphism
that may be associated with greater absorption
of environmental lead and thus an increased
risk for neurodevelopmental toxicity (Haynes
et al. 2003). The Cincinnati center is also inves-
tigating the relationship between early exposure
to lead and adult criminality. The interactions
of a history of early lead poisoning with four
polymorphisms associated with dopamine and
serotonin reception and/or transport and genes
regulating monoamine oxidase A enzyme activ-
ity are being examined (Reif and Lesch 2003).
Investigators at the University of California at
Davis Children’s Center are investigating the
interaction between speciﬁc GABAA receptor
polymorphisms and autism spectrum disorder
(ASD). It is well known that some of the most
widely used and environmentally persistent pes-
ticides block GABAA receptor chloride channels
within the mammalian central nervous system,
thereby producing hyperexcitability, tremors,
and convulsions, depending on the level of
exposure (Narahishi et al. 1998). Three genes
that encode subunits of ionotropic GABAA
receptors cluster on chromosome 15q11–13.
Maternally inherited duplications of this chro-
mosome account for approximately 1–3% of all
cases of ASD (Veenstra-VanderWeele et al.
2003). The Children’s Centers at Mount Sinai,
Berkeley, and the University of Washington are
examining the relationship of the paraoxynase 1
(PON1) gene in modifying the associations
between organophosphate pesticide exposure
and neurodevelopment. Recent evidence for a
relationship between genetic background and
susceptibility to the neurobehavioral toxicity of
Lessons learned for neurodevelopmental assessment
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in mice (Hornig et al. 2004) further under-
scores the need to consider gene–environment
interactions to identify susceptible populations.
Conclusions and
Recommendations
• Long-term studies that follow participants into
adolescence and early adulthood are essential
to assess the full range of neurodevelopmental
consequences of exposure to environmental
chemicals. The vast and rapid growth of
human neurobehavioral capacities from birth
through early adulthood means that the func-
tional effects of earlier damage may not be
fully expressed at any given moment in time.
• Compounds targeted for investigation should
be those that represent plausible neuro-
developmental hazards to fetal and postnatal
central nervous system development. The
compounds under investigation should rep-
resent a clear hazard to neurodevelopment on
the basis of their biochemical properties.
Most drugs and environmental chemicals
cross the placenta with ease by virtue of their
low molecular weight and many gain access
to the developing central nervous system.
This also requires some knowledge of the
exposure levels that are likely to be encoun-
tered in the environments occupied by the
samples of interest.
• Population factors including ethnicity and
language must be considered in the planning
of study procedures for recruitment, reten-
tion, and selection of neurodevelopmental
measures. Population factors can be particu-
larly important if substantial confounding
and multicultural issues are involved. These
features become crucial when it comes to the
choice of appropriate neurodevelopmental
measures that will accurately reflect the
cognitive and sensorimotor capacities of the
population under investigation. Ideally,
examiners familiar with the language and
culture of the population under study should
be employed.
• The proposed work should be compatible
with the physical and human resources at
hand. Sites faced with populations that are
widely dispersed geographically, having
limited transportation, or lack of trained
personnel will be restricted in the depth of
neurodevelopmental assessments that can be
realistically implemented.
• Neuropsychologic batteries employed in
these studies should include a balance of
those with measures both broad and narrow
in scope. Batteries too narrow in scope can
easily miss deﬁcits associated with environ-
mental chemical exposures. On the other
hand, fine-grained measures of more nar-
rowly deﬁned neurobehavioral domains can
shed light on exposure-specific effects and
brain–behavior relationships. If specific
neurobehavioral domains are targeted for
assessment, their selection should be guided
by hypothesis-driven inference. An assess-
ment battery that includes both broad- and
narrow-band instruments will usually be
optimal.
• Procedures for monitoring the quality of data
collection and scoring should be maintained
throughout the life of the study. Monitoring
of interexaminer reliability and proficiency
should be practiced on a regular basis. In the
event that multiple examiners are required at
a single center, their training and examina-
tion techniques should be explicitly checked,
monitored, and quantitatively recorded. In
multicenter studies, training should be stan-
dardized across sites. This may require annual
meetings and more frequent conference calls
to discuss issues related to administrations
and scoring of tests.
• Data safety and monitoring procedures must
be in place. As health care professionals as well
as researchers, we have a duty to treat study
participants with respect and concern. Referral
of infants and children presenting with suspect
neurologic or developmental signs or symp-
toms should be made through the primary
care provider. In every case, consultation with
the primary caregiver is mandatory.
• The unique needs of study participants
involved in neurodevelopmental assessment
from birth through adulthood must be con-
sidered. Every age presents special challenges.
Assessment of the neonate calls for extensive
training of the examiner(s) and a highly con-
trolled environment. Infants and toddlers
present special challenges with regard to
directing their attention to the demands of
cognitive and sensorimotor tasks. Assessment
of school-age children and adolescents
provides an opportunity to examine a more
differentiated picture of participants’
developmental strengths and weaknesses.
Assessments of the older adolescent and
young adult call for an approach that recog-
nizes a participant’s legal rights as a research
subject and sometimes requires special meas-
ures to assure subject protection and conﬁ-
dentiality of any data that may be obtained.
• New approaches and technologies should be
exploited in future studies. Computer-based
assessment, psychobiologic measures, neural
markers of central nervous system activity,
and especially the promise of advances in
human genetics have the potential to lead to
substantial progress in our understanding of
the effects of environmental chemicals on
fetal and child development.
Final remarks. A battery of tests that can be
universally regarded as valid and reliable for
evaluating the potential impact of neurotoxi-
cants on the developing central nervous system
does not exist. Specific approaches and tests
have been reviewed and recommended based
on the authors’ experiences and ongoing work
in the Children’s Centers and other studies.
The quandary faced by both seasoned investiga-
tors and researchers new to the area when plan-
ning a study was summarized by one
experienced observer: “I cannot recommend
any tests in this endeavor; many are appropri-
ate. Overall strategy, a principled theoretical
framework, and adequately speciﬁed domains
are what count, not tests” (Bernstein 1994).
The vulnerability of the developing human
central nervous system to environmental chem-
ical compounds has been well established. The
contribution of these exposures in utero or
postnatally to the development of disorders of
uncertain etiology such as attentional deficit
hyperactivity disorder or pervasive develop-
mental disorder/autism is not known at pre-
sent. Large-scale human studies such as the
National Children’s Study may provide some
clues. In the ﬁnal analysis, the human neurode-
velopmental phenotype will be more fully
revealed in large-scale studies that take account
of environmental chemical influences, the
social milieu, and complex human genetic
characteristics that we are just beginning to
understand (Hamer 2002).
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